The impact of the COVID-19 pandemic on perioperative chemotherapy for breast cancer.
Kaede BabaMegumi KawamotoKanako MamishinMao UematsuHikari KiyoharaAkira HirotaNobuyuki TakahashiMisao FukudaShota KusuharaHiromichi NakajimaChikako FunasakaTakehiro NakaoChihiro KondohKenichi HaranoNobuaki MatsubaraYoichi NaitoAko HosonoToshikatsu KawasakiToru MukoharaPublished in: Cancer medicine (2023)
Although the impact of the COVID-19 pandemic on perioperative chemotherapy on whole groups of patients was not evident when comparing periods before and after the pandemic, the impact is becoming prominent in parallel with increasing numbers of new COVID-19 cases.